Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Datang Hanfang Pharmaceutical is a specialized pharmaceutical enterprise based in Pu'er, Yunnan Province, China, focusing on the modernization of Traditional Chinese Medicine (TCM). The company integrates the cultivation of medicinal herbs with high-tech extraction and manufacturing processes to produce proprietary Chinese medicines. Its core therapeutic areas include cardiovascular and cerebrovascular diseases, pediatrics, and women's health. Key products such as Dengzhan Shengmai Capsules and Gengnian'an Capsules are widely recognized in the Chinese domestic market for their efficacy and quality. Datang Hanfang is listed on the National Equities Exchange and Quotations (NEEQ) and operates under strict Good Manufacturing Practice (GMP) standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Datang Hanfang Pharmaceutical.